The Fund Grade · free · no account needed
What grade does TSNAX get?
Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.
Fundprints Fund Grade · as of 2026-09-01
Touchstone Sands Capital Select Growth Fund Class A
#27 of 440 graded active funds · growth · large segment peer group
The point · specialist footprint
TSNAX puts more of its book behind proven specialists than 96% of graded funds.
Bottom 20%
Bottom 40%
Middle
Top 40%
● Top 20%
That has mattered: over the past 2.7 years, funds on this rung beat bottom-rung funds by about 3.8 points per quarter, and beat the S&P in 43% of fund-quarters versus their 22%. The evidence argues this fund earns its seat.
2,825 graded funds · 2.7 years of filings, measured as they were published · evidence, not advice
The grade scores this fund's specialist share — the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.
Conviction exposure
54.2%
of the book in specialist-converged names
Late-stage weight
11.8%
of the book in Crowded or Fading names
Active share
83.1%
how far it strays from the index
The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.
Inside the book — top names by stage · as of 2026-09-09
We email you the day it crosses 50% crowded, and where you stand every month.
Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.
The read · what to do with it
TSNAX earns an A grade and ranks 27 out of 440 graded funds, with specialists accounting for 54.2% of its ownership, a genuinely strong conviction signal. Its biggest story is NVDA at nearly 15% weight sitting in Early Conviction stage, meaning proven specialists are still building. The concern is that META at 6.2% and APP and RBLX are all Fading, with specialists actively stepping back from those names.
→ Watch the combined Fading weight in META, APP, and RBLX closely, as specialist exits there could pressure near term returns.
→ NVDA at 14.8% in Early Conviction stage is the fund's strongest evidence based anchor; monitor whether specialist ownership there continues building.
Support leaving these positions
Read from today's disclosed book. Evidence, not advice.
The evidence base updates this week.
The specialists — not the whales — are already positioned for what comes next. Stop finding out last.
Create your free accountNo card required · open the feed in 30 seconds